| Authors: |
Yun H; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany., Narayan N; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Vohra S; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Giotopoulos G; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Mupo A; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Haematological Cancer Genetics, Wellcome Sanger Institute, Cambridge, UK.; Epigenetics Programme, The Babraham Institute, Cambridge, UK., Madrigal P; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Sasca D; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Department of Hematology, Oncology and Pneumology, University Medical Center Mainz, Mainz, Germany., Lara-Astiaso D; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Horton SJ; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Agrawal-Singh S; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Meduri E; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Basheer F; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Marando L; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Gozdecka M; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Haematological Cancer Genetics, Wellcome Sanger Institute, Cambridge, UK., Dovey OM; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Haematological Cancer Genetics, Wellcome Sanger Institute, Cambridge, UK., Castillo-Venzor A; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK., Wang X; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK., Gallipoli P; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, UK., Müller-Tidow C; Department of Medicine V, Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Heidelberg, Germany., Osborne CS; Department of Medical and Molecular Genetics, King's College London, London, UK., Vassiliou GS; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK.; Department of Haematology, University of Cambridge, Cambridge, UK.; Haematological Cancer Genetics, Wellcome Sanger Institute, Cambridge, UK., Huntly BJP; Wellcome - MRC Cambridge Stem Cell Institute, Cambridge, UK. bjph2@cam.ac.uk.; Department of Haematology, University of Cambridge, Cambridge, UK. bjph2@cam.ac.uk. |
